CompareMarketResearchRequest a sample
Home / Healthcare / Breast Cancer Grading Tools

Healthcare · Market report

Breast Cancer Grading Tools Market Size, Share and Forecast 2026-2036

The global breast cancer grading tools market is worth USD 102 mn in 2026 and is forecast to reach USD 490 mn by 2036, growing at a 17.0% CAGR. United States is the largest country market and Histologic grading is the largest by task segment.

USD 102 mnMarket size 2026
USD 490 mnForecast 2036
17.0%CAGR 2026-2036
United StatesLargest country

Request a free sample Jump to the forecast

Report price: Starts from USD 1,999

5 segmentation views25 countries2026 to 2036 yearly forecast

Market overview

The global breast cancer grading tools market is worth USD 102 mn in 2026 and is forecast to reach USD 490 mn by 2036, growing at a 17.0% CAGR. United States is the largest country market and Histologic grading is the largest by task segment.

ScopeAI software that supports breast cancer pathology: histologic grading, HER2 and Ki-67 scoring and lymph node or margin assessment on digital slides, sold to pathology labs and hospitals.
IndustryHealthcare
Value 2025USD 85 mn
Value 2026USD 102 mn
Value 2036USD 490 mn
CAGR 2026-203617.0%
Volume 20262.57 million analyses
Volume 203615.1 million analyses
Average price 2026USD 39.7 per analyse
Report priceStarts from USD 1,999
PublishedNovember 2026

Request a free sample of this report

Breast Cancer Grading Tools market size and forecast, 2026-2036

Exhibit 1The global breast cancer grading tools market is forecast to grow from USD 102 mn in 2026 to USD 490 mn by 2036, more than triplingGlobal market value in USD: 2025 base year, 2026 estimate and forecast to 2036. CAGR 2026 to 2036: 17.0%
Breast Cancer Grading Tools market value, 2025 to 2036Market value by year. 2025: USD 85 mn; 2026: USD 102 mn; 2027: USD 119 mn; 2028: USD 140 mn; 2029: USD 163 mn; 2030: USD 191 mn; 2031: USD 224 mn; 2032: USD 262 mn; 2033: USD 306 mn; 2034: USD 358 mn; 2035: USD 419 mn; 2036: USD 490 mn. Compound annual growth rate 2026 to 2036: 17.0%.2025102 mn2026224 mn2031490 mn203617.0% CAGR

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

YearMarket value
2026USD 102 mn
2027USD 119 mn
2028USD 140 mn
2029USD 163 mn
2030USD 191 mn
2031USD 224 mn
2032USD 262 mn
2033USD 306 mn
2034USD 358 mn
2035USD 419 mn
2036USD 490 mn

Breast Cancer Grading Tools market segmentation

By task

Exhibit 2Histologic grading is the largest segment by task, with 40.0% of 2026 revenueEstimated share of 2026 global revenue, by task
Breast Cancer Grading Tools market share by task, 2026Share of 2026 revenue by task. Histologic grading: 40.0%; HER2 and Ki-67 scoring: 36.0%; Lymph node and margin assessment: 24.0%.Histologic grading40.0%HER2 and Ki-67 scoring36.0%Lymph node and margin assessment24.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Histologic grading40.0%36.7%USD 41 mn16.0%
HER2 and Ki-67 scoring36.0%39.2%USD 37 mn18.0%
Lymph node and margin assessment24.0%24.0%USD 24 mn17.0%

By deployment

Exhibit 3Cloud adds the most revenue by deployment, growing from USD 49 mn in 2026 to USD 282 mn by 2036Estimated revenue in USD by deployment, 2026 and 2036 forecast
Breast Cancer Grading Tools market by deployment, 2026 and 2036Revenue by deployment in 2026 and 2036. Cloud: USD 49 mn in 2026, USD 282 mn in 2036, change +476%; On-premise: USD 35 mn in 2026, USD 119 mn in 2036, change +243%; Embedded in scanner or laboratory system: USD 18 mn in 2026, USD 89 mn in 2036, change +386%.20262036 forecastChangeCloud+476%49 mn282 mnOn-premise+243%35 mn119 mnEmbedded in scanner or laboratory system+386%18 mn89 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Cloud48.0%57.5%USD 49 mn19.1%
On-premise34.0%24.3%USD 35 mn13.1%
Embedded in scanner or laboratory system18.0%18.2%USD 18 mn17.1%

By technology

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Deep learning62.0%70.0%USD 63 mn18.4%
Classical machine learning26.0%20.0%USD 27 mn14.0%
Rule-based image analysis12.0%10.0%USD 12 mn14.9%

By sample

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
H and E stained slides56.0%52.0%USD 57 mn16.1%
IHC slides30.0%31.0%USD 31 mn17.4%
Mammography and radiology14.0%17.0%USD 14 mn19.3%

By end user

SegmentShare 2026Share 2036Value 2026CAGR 2026-36
Hospital pathology labs48.0%44.0%USD 49 mn16.0%
Reference labs30.0%31.0%USD 31 mn17.4%
Research institutes12.0%13.0%USD 12 mn17.9%
Pharma10.0%12.0%USD 10 mn19.1%

Top 25 countries for breast cancer grading tools by revenue

Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.0% of 2026 revenue and the 25 countries below together hold 96.0%.

Exhibit 4United States is the largest country market at USD 39 mn in 2026, and the three largest countries hold 53.0% of global revenueEstimated 2026 revenue in USD and share of the global market, ten largest countries
Breast Cancer Grading Tools market, ten largest countries in 2026Ten largest countries by 2026 revenue. United States: USD 39 mn, 38.0%; China: USD 8.2 mn, 8.0%; Germany: USD 7.1 mn, 7.0%; United Kingdom: USD 7.1 mn, 7.0%; France: USD 4.1 mn, 4.0%; Japan: USD 4.1 mn, 4.0%; Israel: USD 3.1 mn, 3.0%; Italy: USD 3.1 mn, 3.0%; Netherlands: USD 3.1 mn, 3.0%; Canada: USD 3.1 mn, 3.0%.United States39 mn 38.0%China8.2 mn 8.0%Germany7.1 mn 7.0%United Kingdom7.1 mn 7.0%France4.1 mn 4.0%Japan4.1 mn 4.0%Israel3.1 mn 3.0%Italy3.1 mn 3.0%Netherlands3.1 mn 3.0%Canada3.1 mn 3.0%

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

#CountryValue 2026Share 2026Value 2036CAGR 2026-36
1United StatesUSD 39 mn38.0%USD 188 mn17.1%
2ChinaUSD 8.2 mn8.0%USD 47 mn19.1%
3GermanyUSD 7.1 mn7.0%USD 32 mn16.1%
4United KingdomUSD 7.1 mn7.0%USD 33 mn16.7%
5FranceUSD 4.1 mn4.0%USD 18 mn16.1%
6JapanUSD 4.1 mn4.0%USD 17 mn15.4%
7IsraelUSD 3.1 mn3.0%USD 15 mn17.0%
8ItalyUSD 3.1 mn3.0%USD 13 mn15.8%
9NetherlandsUSD 3.1 mn3.0%USD 14 mn16.6%
10CanadaUSD 3.1 mn3.0%USD 14 mn16.6%
11SpainUSD 3.0 mn2.9%USD 14 mn16.9%
12SwedenUSD 2.3 mn2.2%USD 11 mn16.9%
13BelgiumUSD 2.1 mn2.0%USD 9.9 mn16.9%
14SwitzerlandUSD 1.6 mn1.6%USD 7.8 mn17.0%
15AustraliaUSD 1.5 mn1.4%USD 7.0 mn16.9%
16DenmarkUSD 1.1 mn1.1%USD 5.4 mn16.9%
17South KoreaUSD 0.88 mn0.9%USD 4.7 mn18.3%
18BrazilUSD 0.73 mn0.7%USD 4.0 mn18.4%
19IndiaUSD 0.73 mn0.7%USD 3.9 mn18.2%
20SingaporeUSD 0.66 mn0.7%USD 3.6 mn18.4%
21TaiwanUSD 0.48 mn0.5%USD 2.5 mn18.2%
22AustriaUSD 0.37 mn0.4%USD 1.8 mn17.0%
23FinlandUSD 0.37 mn0.4%USD 1.8 mn17.0%
24PolandUSD 0.29 mn0.3%USD 1.5 mn18.2%
25NorwayUSD 0.26 mn0.2%USD 1.2 mn17.0%
Rest of worldUSD 4.1 mn4.0%USD 18 mn16.2%
Exhibit 5United States and China account for 48% of the USD 388 mn the market is forecast to add by 2036Forecast revenue added between 2026 and 2036 by country, in USD
Breast Cancer Grading Tools market, where the growth to 2036 comes fromRevenue added between 2026 and 2036. Market value 2026: USD 102 mn. United States: +USD 149 mn; China: +USD 39 mn; United Kingdom: +USD 26 mn; Germany: +USD 25 mn; France: +USD 14 mn; 20 other countries: +USD 121 mn; Rest of world: +USD 14 mn. Market value 2036: USD 490 mn.Market value 2026102 mnUnited States+149 mnChina+39 mnUnited Kingdom+26 mnGermany+25 mnFrance+14 mn20 other countries+121 mnRest of world+14 mnMarket value 2036490 mn

Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.

Competitive landscape

Group 1: Global leaders

  • Roche
  • Philips
  • Leica Biosystems

Group 2: Regional and specialist players

  • Ibex Medical Analytics
  • Visiopharm
  • Aiforia
  • Indica Labs
  • 3DHISTECH
  • Techcyte

Group 3: Emerging and niche players

  • Paige
  • Lunit
  • PathAI
  • Proscia
  • Mindpeak
  • Deep Bio
  • Tribun Health

Research methodology

Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the breast cancer grading tools market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.

The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 17.0% is calculated from the resulting values.

The market is divided by task, by deployment, by technology, by sample, by end user. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.

Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.

Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.

Read the full research methodology

Frequently asked questions

How big is the breast cancer grading tools market?

The global breast cancer grading tools market is estimated at USD 85 mn in 2025 and USD 102 mn in 2026.

How fast will the breast cancer grading tools market grow?

It is forecast to reach USD 490 mn by 2036, a compound annual growth rate of 17.0% from 2026, an increase of USD 388 mn.

Which country is the largest market for breast cancer grading tools?

United States is the largest market by revenue at USD 39 mn in 2026, 38.0% of the global total. The three largest countries together hold 53.0%.

Which country is growing fastest?

Among the ten largest markets, China is growing fastest at 19.1% a year from 2026 to 2036.

Which breast cancer grading tools segment is largest?

In the by task split, Histologic grading is the largest segment with 40.0% of 2026 revenue.

Who are the leading breast cancer grading tools companies?

Global leaders include Roche, Philips, Leica Biosystems.

Need the full report?

Request a sample to see the structure, tables and country detail.

Request a free sample

Related markets in Healthcare

← Brachytherapy Treatment Planning Systems CRISPR and Cas Gene →

All Healthcare markets →

Request a sample